ADI CEO exercises options, sells 10k shares
Analog Devices Inc. Chair & CEO Vincent Roche reported an option exercise and related share sale in company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Analog Devices Inc. Chair & CEO Vincent Roche reported an option exercise and related share sale in company stock. On June 1, 2026, he exercised 10,000 shares from a non-qualified stock option at $108.08 per share and sold 10,000 shares at $404.25 per share.
The filing shows this sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025, indicating it was scheduled in advance. After these transactions, Roche directly holds 137,537.875 shares of common stock and has additional indirect holdings of 50,000 shares and 23,515 shares in separate Grantor Retained Annuity Trusts.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($2.96M approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
ROCHE VINCENT
Role
Chair & CEO
Sold
10,000 shs ($4.04M)
Approx. gross sale proceeds
$4.04M
Approx. exercise cost
$1.08M
Approx. pre-tax spread
$2.96M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $108.08 | $1.08M |
| Exercise | Comm Stock - $.16-2/3 value | 10,000 | $108.08 | $1.08M |
| Sale | Comm Stock - $.16-2/3 value | 10,000 | $404.25 | $4.04M |
| holding | Comm Stock-$.16-2/3 value | -- | -- | -- |
| holding | Comm Stock-$.16-2/3 value | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 90,803 contracts (Direct);
Comm Stock - $.16-2/3 value — 137,537.875 shares (Direct);
Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust);
Comm Stock-$.16-2/3 value — 50,000 shares (Indirect, Vincent Roche 2026 Grantor Retained Annuity Trust)
Footnotes (4)
- F1. These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 3, 2025.
- F2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.
- F3. Shares held by the Vincent Roche 2026 Grantor Retained Annuity Trust dated January 11, 2026.
- F4. This option is fully vested.
Key Figures
Shares sold: 10,000 shares
Sale price: $404.25 per share
Options exercised: 10,000 shares
+4 more
7 metrics
Shares sold
10,000 shares
Open-market sale of common stock on June 1, 2026
Sale price
$404.25 per share
Price for 10,000 common shares sold
Options exercised
10,000 shares
Non-qualified stock option exercise on June 1, 2026
Exercise price
$108.08 per share
Strike price of exercised non-qualified stock option
Direct holdings after
137,537.875 shares
ADI common shares held directly by Vincent Roche after transactions
2026 GRAT holdings
50,000 shares
Indirect holdings in Vincent Roche 2026 Grantor Retained Annuity Trust
2024 GRAT holdings
23,515 shares
Indirect holdings in Vincent Roche 2024 Grantor Retained Annuity Trust
Key Terms
Rule 10b5-1, Grantor Retained Annuity Trust, Non-Qualified Stock Option, derivative exercise/conversion, +1 more
5 terms
Rule 10b5-1 regulatory
"These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Grantor Retained Annuity Trust financial
"Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024."
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ADI CEO Vincent Roche report on June 1, 2026?
Vincent Roche reported exercising 10,000 Analog Devices (ADI) stock options at $108.08 and selling 10,000 common shares at $404.25. These transactions occurred on June 1, 2026 and were disclosed in a Form 4 insider trading report.
What stock option did the Analog Devices (ADI) CEO exercise in June 2026?
Vincent Roche exercised a non-qualified stock option covering 10,000 Analog Devices (ADI) shares at an exercise price of $108.08 per share. The option is fully vested and relates to common stock with a stated value of $.16-2/3 per share.
What does a Rule 10b5-1 plan mean for Analog Devices (ADI) insider sales?
A Rule 10b5-1 plan allows Analog Devices (ADI) insiders to pre-schedule trades when they are not aware of material nonpublic information. Roche’s sale under such a plan suggests the transaction timing was pre-arranged rather than an opportunistic market-timing decision.
AI-generated analysis. How Rhea-AI works. Not financial advice.
